U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 207534

Expand all

SYMJEPI (EPINEPHRINE)
0.15MG/0.3ML (0.15MG/0.3ML)
Marketing Status: Prescription
Active Ingredient: EPINEPHRINE
Proprietary Name: SYMJEPI
Dosage Form; Route of Administration: SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS
Strength: 0.15MG/0.3ML (0.15MG/0.3ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N207534
Product Number: 002
Approval Date: Sep 27, 2018
Applicant Holder Full Name: ADAMIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
SYMJEPI (EPINEPHRINE)
0.3MG/0.3ML (0.3MG/0.3ML)
Marketing Status: Prescription
Active Ingredient: EPINEPHRINE
Proprietary Name: SYMJEPI
Dosage Form; Route of Administration: SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS
Strength: 0.3MG/0.3ML (0.3MG/0.3ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N207534
Product Number: 001
Approval Date: Jun 15, 2017
Applicant Holder Full Name: ADAMIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top